Comparison

Evofosfamide European Partner

Item no. TMO-T3615-2mg
Manufacturer TargetMol
CASRN 918633-87-1
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1.Li Shengrong,et al. Biological Trace Element Research (2010), 136(3), 294-301.;Liu Q, et al. Y Chemother Pharmacol. 2012 Jun;69(6):1487-98.;
Smiles Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+]([O-])=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias TH-302
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
449.04
Description
Evofosfamide (TH-302) is a hypoxia-activated prodrug of the cytotoxin bromo-isophosphoramide mustard (Br-IPM) conjugated with 2-nitroimidazole, possessing potential antineoplastic activity. Under hypoxic conditions, typical of hypoxic tumors, the 2-nitroimidazole moiety is reduced, releasing the DNA-alkylating Br-IPM moiety, which induces intra- and inter-strand DNA crosslinks that inhibit DNA replication and cell division, potentially causing apoptosis in tumor cells. The inactive form of the prodrug remains stable under normoxic conditions, which may reduce systemic toxicity.
Pathways
Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close